Old Web
English
Sign In
Acemap
>
Paper
>
COVID-19 convalescent plasma therapy for immunodeficient patients-weighing up risks and benefits.
COVID-19 convalescent plasma therapy for immunodeficient patients-weighing up risks and benefits.
2021
Tomislav Vuk
Ana Hećimović
Irena Jukić
S. Ravlić
Tihana Kurtović
D. Rnjak
Beata Halassy
Keywords:
Intensive care medicine
risks and benefits
convalescent plasma
Coronavirus disease 2019
severe acute respiratory syndrome coronavirus 2
Medicine
2019 20 coronavirus outbreak
Correction
Source
Cite
Save
Machine Reading By IdeaReader
9
References
1
Citations
NaN
KQI
[]